Antiplatelet therapy to prevent recurrent stroke: Three good options.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 24307163.
- Also identified by DOI 10.3949/ccjm.80a.12149.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Drugs that prevent platelets from sticking together-ie, aspirin, dipyridamole, and clopidogrel-are an important part of therapy to prevent recurrence of ischemic stroke of atherosclerotic origin. We discuss current indications for these drugs and review the evidence behind our current use of aspirin, dipyridamole, and clopidogrel.
Medical subject headings
- Aspirin
- Dipyridamole
- Platelet Aggregation Inhibitors
- Stroke
- Ticlopidine